Celebrex and Metformin for Postoperative Hepatocellular Carcinoma
Clinical trial NCT03184493 · UNKNOWN
Trial details
- NCT number
- NCT03184493
- Sponsor
- Guangxi Medical University
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-02
- Primary completion
- 2020-12-01
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.